Home -> Law Blog Directory -> Intellectual Property Law Blogs -> The Trade Secrets Vault

Intellectual Property Law

: The Trade Secrets Vault

Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon?s Warhorse Retires, & More Seattle-Area Life Sciences News

LUKE TIMMERMAN XCONOMY Dendreon (NASDAQ: DNDN) said that David Urdal, the chief scientific officer who lived through the company's roller coaster story over the past 15 years, plans to retire at the end of 2011. Urdal, 62, says it's time for him to spend some more time with his grandchildren. But I don't think this is the last we've heard from Mr. Urdal-so stay tuned for more in these pages. The other big move in town happened on the academic side of biotech, where Alan Aderem left his faculty post at the Institute for Systems Biology to become the new director and president-in-waiting at Seattle Biomedical Research Institute. Aderem is taking more than 40 people with him to Seattle BioMed, plus all his grant support, and a new $7 million donation from the Bill & Melinda Gates Foundation to help bring systems biology to global health.e. To continue reading this interesting article from SeattlePi Xconomy, please click here.

Full post as published by The Trade Secrets Vault on March 17, 2011 (boomark / email).